TuBerculosis Vaccine Initiative
Lelystad, Netherlands
Purpose
to support the critical process to update stage gating criteria for product development of new TB vaccines. This investment is to support TBVI to accomplish this with Aeras.
Division
Global Health
Date
April 2017
Region Served
EUROPE
Committed amount
$997,036
Grant topic
Tuberculosis
Duration (months)
51
Grantee location
Lelystad, Netherlands
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.